Pharma Journalist -

Amgen and Five Prime Therapeutics a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, announced an agreement under which Amgen…
Read More...

ALX Oncology Holdings Inc. a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, and Tallac Therapeutics, Inc. (“Tallac”), a privately…
Read More...

Vir Biotechnology, Inc. and GlaxoSmithKline plc provided an update on the VIR-7831 (GSK4182136) arm of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic…
Read More...

The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA (lorlatinib), expanding the indication to include…
Read More...

Tempest Therapeutics, Inc., a clinical-stage oncology company developing first-in-class therapeutics that combine both precision and immune-mediated mechanisms, announced a clinical…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc. a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological…
Read More...

Vaxalto Biotherapeutics, Inc. (www.vaxalto.com), a pre-clinical stage biotechnology company focused on developing and commercializing novel engineered immunotherapeutic oncolytic…
Read More...

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, announced final efficacy data…
Read More...

WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, announced that it has…
Read More...

ObvioHealth, a global virtual research organization or VRO, announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital…
Read More...